Cargando…
Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice
BACKGROUND: Loss of skeletal muscle mass and function in humans is associated with significant morbidity and mortality. The role of myostatin as a key negative regulator of skeletal muscle mass and function has supported the concept that inactivation of myostatin could be a useful approach for treat...
Autores principales: | Latres, Esther, Pangilinan, Jeffrey, Miloscio, Lawrence, Bauerlein, Roy, Na, Erqian, Potocky, Terra B., Huang, Ying, Eckersdorff, Mark, Rafique, Ashique, Mastaitis, Jason, Lin, Calvin, Murphy, Andrew J., Yancopoulos, George D., Gromada, Jesper, Stitt, Trevor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600334/ https://www.ncbi.nlm.nih.gov/pubmed/26457176 http://dx.doi.org/10.1186/s13395-015-0060-8 |
Ejemplares similares
-
Activin A more prominently regulates muscle mass in primates than does GDF8
por: Latres, Esther, et al.
Publicado: (2017) -
Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy
por: Lee, Yun-Sil, et al.
Publicado: (2015) -
Myostatin in the Pathophysiology of Skeletal Muscle
por: Carnac, Gilles, et al.
Publicado: (2007) -
Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin
por: Winbanks, Catherine E., et al.
Publicado: (2012) -
Inhibition of Activin/Myostatin signalling induces skeletal muscle hypertrophy but impairs mouse testicular development
por: Vaughan, Danielle, et al.
Publicado: (2020)